Sucampo Pharmaceuticals, Inc.Bethesda, MD, United States (NASDAQ (GM): SCMP)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Sucampo Financial Statements

Sucampo Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Edgar Online logo
This data is provided as per license from EDGAR Online

Sucampo Income Statement

  2007 2006 2005
Revenue ($ mil.) 91.9 59.3 40.2
Gross Profit ($ mil.) -- -- --
Operating Income ($ mil.) 18.4 14.8 (0.5)
Total Net Income ($ mil.) 13.2 21.8 (0.3)
Diluted EPS (Net Income) 0.35 0.63 (0.01)
More Sucampo financial information

Sucampo Stock Quote & Chart

09/05/08 15:00:06 EST • NASDAQ • 10.36 • Increased by +0.7300 • Increased by +7.5805 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Sucampo Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 1.37 3.54 1.52
Price/Earnings Ratio 14.58 14.95 15.55
Price/Book Ratio 1.31 2.88 1.47
Price/Cash Flow Ratio 2.21 12.37 9.50
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Sucampo Financial Ratios

Sucampo Competitive Intelligence

Alizyme Novartis Corporation Solvay Pharmaceuticals
Annual Sales ($ mil.) 0.0 12,587.0 66.8
Employees 20 22,391 530
Market Cap ($ mil.) -- -- --

Competitive Landscape